AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?

The cytoprotective effects of MK-801 and NBQX, selective N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor antagonists, respectively, were compared both singularly and in combination in models of transient severe forebrain and transient focal c...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Buchan, A, Lesiuk, H, Barnes, K, Li, H, Huang, Z, Smith, K, Xue, D
Formáid: Journal article
Teanga:English
Foilsithe / Cruthaithe: 1993

Míreanna comhchosúla